Pulmonary arterial hypertension in SLE: what do we know?
about
Baseline Characteristics and Risk Factors of Pulmonary Arterial Hypertension in Systemic Lupus Erythematosus Patients.Characteristics and Survival of Anti-U1 RNP Antibody-Positive Patients With Connective Tissue Disease-Associated Pulmonary Arterial Hypertension.Chinese SLE Treatment and Research group (CSTAR) registry: II. Prevalence and risk factors of pulmonary arterial hypertension in Chinese patients with systemic lupus erythematosus.Immune regulation of systemic hypertension, pulmonary arterial hypertension, and preeclampsia: shared disease mechanisms and translational opportunities.Could pulmonary arterial hypertension be an active index of systemic lupus erythematosus? A successful case of SLE-PAH cured by methylprednisolone pulse therapy.Evaluation of pulmonary artery pressure in patients with juvenile systemic lupus erythematosus (jSLE).
P2860
Pulmonary arterial hypertension in SLE: what do we know?
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Pulmonary arterial hypertension in SLE: what do we know?
@en
Pulmonary arterial hypertension in SLE: what do we know?
@nl
type
label
Pulmonary arterial hypertension in SLE: what do we know?
@en
Pulmonary arterial hypertension in SLE: what do we know?
@nl
prefLabel
Pulmonary arterial hypertension in SLE: what do we know?
@en
Pulmonary arterial hypertension in SLE: what do we know?
@nl
P2860
P356
P1433
P1476
Pulmonary arterial hypertension in SLE: what do we know?
@en
P2093
P2860
P304
P356
10.1177/0961203313505010
P577
2013-10-01T00:00:00Z